We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-5.97%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$13.6B
AUM Growth
-$228M
Cap. Flow
+$864M
Cap. Flow %
6.34%
Top 10 Hldgs %
11.84%
Holding
3,164
New
256
Increased
959
Reduced
778
Closed
260

Top Sells

Rank Stock Value
1
M icon
Macy's
M
+$55.7M
2
GLW icon
Corning
GLW
+$49.4M
3
LUV icon
Southwest Airlines
LUV
+$36.6M
4
TXN icon
Texas Instruments
TXN
+$34.1M
5
EBAY icon
eBay
EBAY
+$34M

Sector Composition

Rank Sector Weight
1 Technology 15.4%
2 Healthcare 14.04%
3 Financials 12.22%
4 Industrials 11.09%
5 Consumer Discretionary 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSY icon
326
Hershey
HSY
$35.4B
$10.3M 0.08%
112,250
+870
+0.8% +$79.3K
JCI icon
327
Johnson Controls International
JCI
$87.5B
$10.1M 0.07%
233,687
-14,547
-6% -$671K
ALE
328
DELISTED
Allete
ALE
$10.1M 0.07%
199,870
+199,760
+181,600% +$9.69M
GPC icon
329
Genuine Parts
GPC
$17.1B
$10.1M 0.07%
121,461
+3,152
+3% +$271K
JWN
330
DELISTED
Nordstrom
JWN
$10M 0.07%
139,687
-721
-0.5% -$54.3K
ARCB icon
331
ArcBest
ARCB
$3.44B
$9.91M 0.07%
384,499
-84,613
-18% -$2.55M
BDX icon
332
Becton Dickinson
BDX
$43.1B
$9.65M 0.07%
74,554
-55
-0.1% -$7.68K
JAZZ icon
333
Jazz Pharmaceuticals
JAZZ
$15.9B
$9.63M 0.07%
72,504
+72,494
+724,940% +$12.5M
ADBE icon
334
Adobe
ADBE
$89.5B
$9.48M 0.07%
115,357
+13,729
+14% +$1.11M
NSC icon
335
Norfolk Southern
NSC
$78.8B
$9.48M 0.07%
124,047
+16,704
+16% +$1.36M
ANIP icon
336
ANI Pharmaceuticals
ANIP
$1.77B
$9.45M 0.07%
+239,113
New +$13.6M
IFF icon
337
International Flavors & Fragrances
IFF
$19.4B
$9.4M 0.07%
91,083
-2,373
-3% -$262K
PCP
338
DELISTED
PRECISION CASTPARTS CORP
PCP
$9.34M 0.07%
40,652
-29,735
-42% -$6.38M
IDA icon
339
Idacorp
IDA
$8.23B
$9.23M 0.07%
142,696
+142,597
+144,037% +$8.6M
FITB
340
Fifth Third Bancorp
FITB
$52B
$9.07M 0.07%
479,850
-2,518
-0.5% -$51.2K
NJR icon
341
New Jersey Resources
NJR
$6.06B
$9.05M 0.07%
301,520
+295,707
+5,087% +$8.41M
RNR icon
342
RenaissanceRe
RNR
$13.7B
$9.04M 0.07%
85,058
+11
+0% +$1.15K
PXF icon
343
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.83B
$8.82M 0.06%
246,776
-329,122
-57% -$12.8M
NVDA icon
344
NVIDIA
NVDA
$5.01T
$8.76M 0.06%
14,221,080
-31,598,480
-69% -$17.1M
GLW icon
345
Corning
GLW
$126B
$8.54M 0.06%
498,957
-2,746,457
-85% -$49.4M
CAT icon
346
Caterpillar
CAT
$409B
$8.53M 0.06%
130,567
-11,406
-8% -$872K
CCEP icon
347
Coca-Cola Europacific Partners
CCEP
$46.5B
$8.29M 0.06%
171,462
-23,296
-12% -$1.13M
BIIB icon
348
Biogen
BIIB
$29.9B
$8.24M 0.06%
28,238
-42,581
-60% -$14.1M
CTAS icon
349
Cintas
CTAS
$82.4B
$8.22M 0.06%
383,540
-56
-0% -$1.2K
DGX icon
350
Quest Diagnostics
DGX
$25.1B
$8.2M 0.06%
133,362
-154,304
-54% -$10.8M

Similar funds

Glenmede Trust's Q3 2015 Portfolio in Review

As of Q3 2015, Glenmede Trust held 3,164 positions worth $13.6B, down 1.6% from $13.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Glenmede Trust deployed $864M of net new capital in Q3 2015, opening 256 new positions and adding to 959 existing holdings. Its largest new stake was PayPal: 1,978,444 shares worth $61.4M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Macy's, an estimated $55.7M trimmed.

  • Glenmede Trust's largest Q3 2015 buy was PayPal: 1,978,444 shares worth $61.4M.
  • Glenmede Trust added most to Omnicom Group in Q3 2015, an estimated $59.3M increase.
  • Glenmede Trust's biggest Q3 2015 reduction was Macy's, cutting an estimated $55.7M.
  • Glenmede Trust fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015, selling an estimated $18.8M.
  • Glenmede Trust's ten largest holdings make up 12% of its $13.6B portfolio in Q3 2015.
  • Glenmede Trust opened 256 new positions and closed 260 in Q3 2015.
  • Glenmede Trust's portfolio value fell 1.6% quarter-over-quarter to $13.6B.

Based on Glenmede Trust's 13F filing for Q3 2015, filed 12 Nov 2015.